Kits Eyecare Stock Performance
| KTYCF Stock | USD 13.12 0.32 2.50% |
On a scale of 0 to 100, Kits Eyecare holds a performance score of 5. The company secures a Beta (Market Risk) of 1.93, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kits Eyecare will likely underperform. Please check Kits Eyecare's expected short fall, and the relationship between the value at risk and rate of daily change , to make a quick decision on whether Kits Eyecare's current price movements will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Kits Eyecare are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Kits Eyecare reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.3 M | |
| Total Cashflows From Investing Activities | -3.6 M |
Kits |
Kits Eyecare Relative Risk vs. Return Landscape
If you would invest 1,157 in Kits Eyecare on September 27, 2025 and sell it today you would earn a total of 155.00 from holding Kits Eyecare or generate 13.4% return on investment over 90 days. Kits Eyecare is currently producing 0.2708% returns and takes up 3.8433% volatility of returns over 90 trading days. Put another way, 34% of traded pink sheets are less volatile than Kits, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Kits Eyecare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kits Eyecare's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Kits Eyecare, and traders can use it to determine the average amount a Kits Eyecare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0704
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | KTYCF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Kits Eyecare is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kits Eyecare by adding it to a well-diversified portfolio.
Kits Eyecare Fundamentals Growth
Kits Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Kits Eyecare, and Kits Eyecare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kits Pink Sheet performance.
| Return On Equity | -0.13 | |||
| Return On Asset | -0.0838 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | (0.15) % | |||
| Current Valuation | 56.77 M | |||
| Shares Outstanding | 31.29 M | |||
| Price To Book | 1.41 X | |||
| Price To Sales | 0.67 X | |||
| Revenue | 82.4 M | |||
| EBITDA | (14.68 M) | |||
| Cash And Equivalents | 18.89 M | |||
| Cash Per Share | 0.60 X | |||
| Total Debt | 13.04 M | |||
| Debt To Equity | 0.40 % | |||
| Book Value Per Share | 1.76 X | |||
| Cash Flow From Operations | (19.46 M) | |||
| Earnings Per Share | (0.33) X | |||
| Total Asset | 90.94 M | |||
About Kits Eyecare Performance
By analyzing Kits Eyecare's fundamental ratios, stakeholders can gain valuable insights into Kits Eyecare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kits Eyecare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kits Eyecare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kits Eyecare Ltd. operates a digital eyecare platform for eyes in the United States and Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Kits Eyecare operates under Specialty Retail classification in the United States and is traded on OTC Exchange. It employs 95 people.Things to note about Kits Eyecare performance evaluation
Checking the ongoing alerts about Kits Eyecare for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Kits Eyecare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kits Eyecare had very high historical volatility over the last 90 days | |
| The company reported the revenue of 82.4 M. Net Loss for the year was (14.62 M) with profit before overhead, payroll, taxes, and interest of 20.89 M. | |
| Kits Eyecare has accumulated about 18.89 M in cash with (19.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6. | |
| Roughly 77.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Kits Eyecare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kits Eyecare's stock is overvalued or undervalued compared to its peers.
- Examining Kits Eyecare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kits Eyecare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kits Eyecare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Kits Eyecare's pink sheet. These opinions can provide insight into Kits Eyecare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kits Pink Sheet analysis
When running Kits Eyecare's price analysis, check to measure Kits Eyecare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kits Eyecare is operating at the current time. Most of Kits Eyecare's value examination focuses on studying past and present price action to predict the probability of Kits Eyecare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kits Eyecare's price. Additionally, you may evaluate how the addition of Kits Eyecare to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |